Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations.

Justin R ArnallKathryn T MaplesR Donald HarveyDonald C Moore

Published in: The Annals of pharmacotherapy (2021)

Daratumumab has led to a shift in the treatment paradigm of both newly diagnosed and relapsed/refractory MM, leading to improvements in outcomes such as response rates, depth of response, and progression-free survival.

Keyphrases

multiple myeloma
free survival
newly diagnosed
acute lymphoblastic leukemia
acute myeloid leukemia
type diabetes
adipose tissue
combination therapy
skeletal muscle
smoking cessation